Products for Research Use Only
RegisterLogin

HTH-01-091

CAT: 0804-HY-122665-01Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-122665-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
HTH-01-091 is a potent and selective maternal embryonic leucine zipper kinase (MELK) inhibitor, with an IC50 of 10.5 nM. HTH-01-091 also inhibits PIM1/2/3, RIPK2, DYRK3, smMLCK and CLK2. HTH-01-091 can be uesd for breast cancer research[1].
CAS Number
2000209-42-5
UNSPSC
12352005
Target
CDK; DYRK; GSK-3; MELK; mTOR; Pim; RIP kinase
Type
Reference compound
Related Pathways
Apoptosis; Cell Cycle/DNA Damage; JAK/STAT Signaling; PI3K/Akt/mTOR; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/hth-01-091.html
Purity
98.64
Solubility
DMSO : 12.5 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C1N([C@H]2CC[C@H](CN(C)C)CC2)C3=C(CN1)C=NC4=CC=C(C5=CC(Cl)=C(O)C(Cl)=C5)C=C34
Molecular Formula
C26H28Cl2N4O2
Molecular Weight
499.43
References & Citations
[1]Huang HT, et al. MELK is not necessary for the proliferation of basal-like breast cancer cells. Elife. 2017 Sep 19;6:e26693.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CDK7; DYRK4; mTOR; PIM1; PIM2; PIM3; RIPK2

Related Products

CatalogName
HY-12334-01HTH-01-015
HY-163154JJC8-091
HY-120572PI-091
HY-139868-01BAY-091
HY-156397-01HTH-02-006
HY-122209DVR-01
HY-137464A-01OATD-01
HY-161768VCC972839:01
HY-106839NKS-01
HY-155870DL-01

Alternative Products

CatalogName
BA3509-5HTH-01-091
GTR19221583-01HTH-01-091 TFA
A8890-200HTH-01-015
5622/50HTH 01-015

Popular Products